Volume 3, Number 6, Supplement 4 (November/December 2005)

Multidisciplinary Care in Cancer Management
Selected Reviews on the Treatment of
Anemia, Neutropenia, and Symptom Clusters

Ann M. Berger, RN, PhD, AOCN Guest Editor

From presentations at the 30th Annual Congress of the Oncology Nursing Society, April 27–May 1, 2005, Orlando, Florida

Jointly sponsored by Mosby’s Continuing Education and Training, the University of Medicine and Dentistry of New Jersey, and Elsevier Oncology

Information About This Continuing Education Activity
Program Goal • Educational Objectives • Target Audience • Method of Instruction • Pharmacy Content Reviewer • Faculty Disclosure • Accreditation • Unapproved/Off-Label Use Disclosure

full text 33 kb
Release date: October 27, 2005 • Expiration date: October 27, 2006

Introduction

3

  

Selected Reviews on the Treatment of Anemia, Neutropenia, and Symptom Clusters
Ann M. Berger, RN, PhD, AOCN, Guest Editor

College of Nursing, University of Nebraska Medical Center, Omaha

full text 66 kb

Anemia

6

  

Treatment of Anemia With Darbepoetin Alfa in the Radiation Oncology Setting
D. Finney and R.R. Allison

full text 45 kb

8

  

Development of a Strategy to Successfully Convert an Ambulatory Infusion Center From Epoetin Alfa to Darbepoetin Alfa
V. Longfield, B. Gebhart, and L. Hayward

full text 43 kb

10

  

Hemoglobin Response and Improvements in Quality of Life in Anemic Children With Cancer Receiving Myelosuppressive Chemotherapy
P.S. Hinds, M. Hockenberry, J. Feusner, J.D. Hord, W. Rackoff, and B.I. Rozzouk

full text 69 kb

12

  

Advances in Conducting Retrospective Chart Review Studies: Use of Electronic Report Forms and Database in a Community Study in Anemic Patients With Myelodysplastic Syndrome
T. Sullivan, Y. Mun, J.F. Wallace, and J.F. Patton

full text 44 kb

14

  

Optimizing Chemotherapy-Induced Anemia Management With the Use of Patient Flow Sheets
L. Morehead, A. Zobec, C. Pacheco-Gach, R. Glick, and S.B. Flippin

full text 67 kb

16

  

Iron, Folate, and Cancer-Related Anemia: Perfect Together
V. Gaits, A. Shaftic, and J. Terlizzi

full text 44 kb

18

  

A Multidisciplinary Approach for Establishing Standardized Anemia Procedures
D. Miskin and C. Hoechner

full text 44 kb

20

  

Utilizing Quality of Life as a Factor in Treatment Choices for Chemotherapy-Induced Anemia
W. Koopman and S. Iakiri

full text 50 kb

Neutropenia

22

  

Admission and Care of the Febrile Neutropenic Patient in a Community Hospital Setting
M.S. Ford and M. Helsley

full text 43 kb

24

  

Predictors of Chemotherapy-Induced Neutropenia and Its Complications: Results From a Prospective Nationwide Registry
D. Wolff, E. Culakova, M.S. Poniewierski, G.H. Lyman, D.C. Dale, and J. Crawford for the ANC Study Group

full text 49 kb

26

  

Best Practices in Neutropenia Management: You Can Get There From Here
R. Donohue

full text 46 kb

Symptom Clusters

28

  

Identification and Verification of Symptom Clusters in Cancer Patients
M.-L. Chen and H.-H. Tseng

full text 45 kb

30

  

Advancing Our Knowledge of Symptom Clusters
M.J. Dodd, M.H. Cho, B. Cooper, C. Miaskowski, K.A. Lee, and K. Bank

full text 47 kb

32

  

Profile of Cancer-Related Symptoms Prior to Chemotherapy
K. Rowe and S. Schneider

full text 49 kb

34

  

TITAN: Modifying an Innovative American Program for Use With a European Audience
Training Initiatives in Thrombocytopenia, Anemia, and Neutropenia (TITAN) Working Group: K. Ahlberg, P. Dielenseger, S. Dolan, J. Foubert, M. Munoz, J. Ouwerkerk, and M. Uhlenhopp; Appropriate Treatment Assures Quality (ATAQ): D. Wujcik

full text 46 kb

36

  

Baseline Evaluation of Assessment, Information, and Management Patterns in a National Quality Improvement Project
G. Johnson, B. Fortner, K. Moore, K.T. Tauer, L. Zhu, L.S. Schwartzberg, and the AIM Higher Working Group

full text 49 kb

Continuing Education

38

  

CE Post Test, Answer Sheet, and Evaluation

full text 53 kb

This activity is supported by an unrestricted educational grant from Amgen Inc.

© 2005 by Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher.

The opinions expressed herein are those of the authors or advertisers. The authors, editors, and publishers make every effort to ensure that no inaccurate or misleading data, opinion, or statement is published in this journal and that drug names, dosages, and recommendations are accurate. However, readers should confirm all dosage schedules against the manufacturer’s package information data. The Publisher, Editorial Board, and their employees accept no liability whatsoever for the consequences of any inaccurate or misleading data, opinion, or statement.